1. Puerto Rico Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc.

PBSV
Pharma-Bio Serv, Inc.US flagOther OTC
0.50
USD
- -
- -
11.45MMarket Cap
Pharma-Bio Serv, Inc.
PBSV
(Other OTC)

Recent

price

0.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.55
0.96
1.41
1.49
1.2
1.01
0.85
0.58
0.77
0.85
0.94
0.87
0.84
0.74
0.41
0.39
0.4
Revenue per Share
0.02
0.15
0.23
0.22
0.11
0.07
-0.01
-0.06
0.06
0.09
0.09
-0.09
0.04
0.06
-0.03
- -
- -
Basic EPS, GAAP
0.02
0.1
0.11
0.24
0.14
- -
-0.05
-0.04
0.16
-0.1
0.06
0.03
0.02
0.08
-0.03
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
0.07
- -
0.08
0.08
0.15
0.08
0.07
0.07
0.07
Dividend per Share
0.21
0.37
0.59
0.77
0.85
0.92
0.91
0.85
0.83
0.84
0.94
0.77
0.66
0.65
0.54
0.46
0.4
Book Value per Share
0.24
0.4
0.62
0.81
0.89
0.95
0.95
0.9
0.88
0.89
0.99
0.82
0.72
0.7
0.6
0.52
0.46
Tangible Book Value per Share
21
21
21
22
23
23
23
23
23
23
23
23
23
23
23
23
23
Basic Weighted Avg Shares
11
20
29
33
28
23
20
13
18
20
22
20
19
17
10
9
9
Sales/Revenue/Turnover
5.38
17.32
19.62
18.36
10.39
7.62
-0.47
-6.15
6.11
8.7
10.32
-19.16
6.06
6.58
-13.54
-7.08
-4.36
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
3
5
5
2
2
- -
-1
1
2
2
-2
1
1
-1
- -
- -
Net Income, GAAP
40.13
8.8
18.57
19.25
16.14
9.37
- -
- -
182.8
6.12
10.44
- -
15.29
22.36
- -
- -
13.47
Effective Tax Rate (%)
3.28
15.85
16.04
14.84
8.76
6.95
-1.31
-10.64
7.19
10.7
9.51
-10.39
5.19
7.72
-8.18
-1.12
0.67
Profit Margin (%)
4
7
12
17
20
21
19
20
21
22
25
20
18
17
14
12
10
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
LT Debt
5
8
13
18
21
22
22
21
20
21
23
19
17
16
14
12
10
Total Equity
7.12
44.15
42.29
31
12.22
7.52
- -
- -
-4.34
7.63
8.51
- -
5.33
5.05
- -
- -
-5.33
Return on Invested Capital (%)
8.63
51.72
46.61
33.09
13.08
7.96
- -
- -
6.59
10.78
9.36
- -
5.91
8.46
- -
- -
0.62
Return on Capital (%)
8.74
52.45
47.13
33.28
13.12
7.96
-1.22
-6.98
6.62
10.82
10
-10.65
6.1
8.7
-5.72
-0.88
0.62
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'25
Jan'26
Apr'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
23
Market Capitalization
12
14
11

Working Capital

FRC

•

in mil. unless spec.
Oct'25
Jan'26
Apr'26
Total Current Assets
13
13
11
Cash, Cash Equivalents & STI
11
11
8
Accounts Receivable, Net
2
3
3
Inventories
- -
- -
- -
Total Current Liabilities
2
3
1
Payables & Accruals
2
3
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.58%
-11.98%
-13.13%
Free Cash Flow
-459.2%
-10.56%
-69.5%
Net Income, GAAP
-35.98%
-113.27%
-87.08%
Sales/Revenue/Turnover
-6.65%
-14.42%
-5.34%
Total Cash Common Dividend
- -
9.89%
-0.13%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
2
2
2
10
2025
2
2
2
2
9
2026
2
3
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.03
2025
- -
- -
-0.01
- -
- -
2026
- -
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.08
- -
- -
0.07
2025
- -
0.07
- -
- -
0.07
2026
- -
0.07
- -
- -
- -
Similar Companies
M3, Inc. (MTHRY)
Carebook Technologies Inc. (CRBKF)
Volpara Health Technologies Limited (VHT.AX)
Kusurinomadoguchi, Inc. (5592.T)
Vitalhub Corp. (VHIBF)
Media Lab S.p.A. (MLLAB.PA)
Business
Pharma-Bio Serv, Inc. (PBSV) provides integrated regulatory compliance, validation, technology transfer, and quality systems consulting services to highly regulated life sciences manufacturers. The company offers technical compliance consulting including regulatory affairs such as US agent services, establishment registrations, product listings, IND/NDA/BLA/ANDA filings, 510(k) and PMA packages, and post-approval supplements; commissioning, qualification and validation encompassing facilities/utilities/equipment qualification, risk assessments (FMEA, HAZOP), process validation (manufacturing, packaging, cleaning, sterility), computer system validation (21 CFR Part 11), analytical methods development, and capital project management; compliance and quality systems covering gap analyses, PAI readiness, remediation for FDA 483s/warning letters/consent decrees, SOP development, CAPA/change control/deviation management, stability programs, and supplier quality programs; data integrity evaluations and training/workshops on cGMP, regulatory topics (FDA/EMA/ANVISA), validation, human error, and CAPAs; as well as microbiological and chemical laboratory testing services through its Puerto Rico facility. It serves pharmaceutical, biotechnology, medical device, cosmetics, food, beverage, consumer products, and allied industries across more than 30 countries including Puerto Rico, the United States, Europe, Brazil, Canada, Mexico, India, Japan, and others. Founded in 1993 and headquartered in Dorado, Puerto Rico, Pharma-Bio Serv employs over 250 professionals and operates through segments in Puerto Rico technical compliance consulting, US consulting, Europe consulting, and Puerto Rico lab testing. The company reported a net loss of approximately $0.8 million for the fiscal year ended October 31, 2024, compared to prior net income, reflecting ongoing operational challenges amid its focus on expanding holistic service provision globally.

Company News

APIChatGPT

  • accessnewswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

  • accessnewswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026

  • accessnewswire.com

    Pharma-Bio Serv Announces Full Year Results and Special Dividend

  • defenseworld.net

    Analyzing Pharma-Bio Serv (OTCMKTS:PBSV) and ATIF (NASDAQ:ZBAI)

  • defenseworld.net

    ATIF (NASDAQ:ZBAI) and Pharma-Bio Serv (OTCMKTS:PBSV) Financial Analysis

  • accessnewswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025

  • accessnewswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025

  • accessnewswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025

  • accessnewswire.com

    Pharma-Bio Serv Announces Full Year Results

  • accessnewswire.com

    Pharma-Bio Serv Announces Special Dividend

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024

  • accesswire.com

    Pharma-Bio Serv Announces Full Year Results

  • accesswire.com

    Pharma-Bio Serv Announces Special Dividend

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023

  • investorplace.com

    7 Best Penny Stocks Under $1 to Buy in July

  • investorplace.com

    7 Best Penny Stocks Under $1 to Buy Now

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021

  • accesswire.com

    Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021